HC-016

N/A

Report date: 2023/01/12 15:29:11

Base Information

Drug NameHC-016
Drug Alias NameHC-016
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsUrinary Incontinence, StressRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFerrerHistocell Sl
China Registration ClassN/A

Develop Information

Active CompaniesHistocell SlInstituto De Investigación Sanitaria De La Fundación Jiménez Díaz
Inactive CompaniesN/A
Active IndicationsUrinary Incontinence, StressRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A